HOME >> MEDICINE >> NEWS
First head-to-head study to compare lidoderm patch and Celebrex in treating pain

l reductions in pain were noted in both treatment groups at week 12.

"Although these results need to be confirmed with further randomized controlled trials, the potential of Lidoderm to treat osteoarthritis knee pain is promising," added Dr. Kivitz. "Lidoderm has been used since 1999 to treat the pain of post-herpetic neuralgia and, because it is a non-systemic patch, has demonstrated a minimal risk of side effects or drug-to-drug interaction. Our hope is to see similar results in further Lidoderm osteoarthritis knee pain studies."

About the Study
The randomized, open-label, active-control, parallel-group study, which was intended to enroll 200 patients, contained data for 143 patients experiencing OA pain of either one or both knees and evaluated efficacy and safety of treatment. After a 7- to 14-day wash-out period during which all analgesic medications, chondroitin, and glucosamine were discontinued, patients with an average daily pain intensity score of =5 on a scale of 0 to 10 for three of five consecutive days and an OA severity score of =7 on a scale of 0 to 24 prior to the baseline visit were randomized to 12 weeks of treatment with either one full Lidoderm patch on the front of the knee and one-third of a patch on the back of each affected knee (69 patients) once daily for 24 hours or Celebrex 200 mg once daily (74 patients). Efficacy measures included the Western Ontario and McMaster Universities OA Index, Brief Pain Index (BPI), Pain Quality Assessment Scale and global assessments of change in OA pain and treatment satisfaction.

In the study, both treatments were well tolerated, with adverse events reported in eight patients in each group. The most common adverse events were itchiness or redness at the patch site. Additionally, three patients in the Lidoderm group discontinued the study due to adverse events. There were no discontinuations due to treatment-related adverse events in the Celebrex gro
'"/>

Contact: Fiona Buraimoh
fiona_buraimoh@nyc.cohnwolfe.com
212-798-9512
Cohn & Wolfe
31-Mar-2005


Page: 1 2 3

Related medicine news :

1. First UK cases of previously rare disease reported in gay men
2. First mouse model for multiple system atrophy points to new treatment targets for brain diseases
3. Mayo Clinic researchers create obedient virus; First step to use measles virus against cancer
4. First US kidney cancer vaccine trial underway at Columbia
5. First new treatment for alcoholism in ten years, now available Campral(R) (acamprosate calcium)
6. First blood test to diagnose paralyzing, blinding disease
7. First US SARS vaccine trial opens at NIH
8. First-ever safety study of medical cannabis use in Canada launched
9. First solid evidence that the study of music promotes intellectual development
10. First medical test on CD gets good results
11. First proof that cutting Rx drugs due to cost harms health

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2018)... (PRWEB) , ... August 31, 2018 , ... ... hospitals | 2018" list. , This list includes independent community hospitals as well ... while others care for small communities outside of large cities. The hospitals continue ...
(Date:8/31/2018)... ... 2018 , ... The social impact documentary feature film on homelessness, OFF THE ... researcher Luciana Lagana, aka Dr. Luciana, has been faring well at film festivals ... Festival, IndieFEST Film Awards, Shawna Shea Memorial Film Festival, and Top Indie Film Awards. ...
(Date:8/31/2018)... ... August 31, 2018 , ... ... the impact of a biofield energy treated nutraceutical to improve overall immunity and ... immune function and blood, as well as, inflammation. The following data was reported:, ...
(Date:8/31/2018)... ... August 31, 2018 , ... ZPower, ... promotion of Nitin Arneja to Chief Information Officer. Arneja previously served as Director ... develop technology solutions that protect, optimize, scale, and innovate the business. , ...
(Date:8/29/2018)... ... August 29, 2018 , ... ... new immunization module that allows independent pharmacies to start or enhance immunization ... service-oriented independent pharmacies are moving toward providing immunization programs in order to ...
Breaking Medicine News(10 mins):
(Date:9/7/2018)... ... 06, 2018 , ... CTL Medical Corporation has entered into ... business, which includes its complete portfolio of spine-related patents and 510ks, as well ... The deal will make CTL Medical the world’s exclusive provider of silicon nitride ...
(Date:9/3/2018)... S.C. (PRWEB) , ... September 03, 2018 , ... ... the twenty-fourth-largest number of residents with more than 1,200 residents and 200 fellows ... rank South Carolina twenty-third-largest in the nation. Charleston area institutions such as McLeod ...
(Date:9/1/2018)... ... , ... Dr. Payam Bostani is now offering Periodontal Osseous (bone) surgeries alongside ... patients for twenty years at his Burbank offices. “My goal has always been ... under a single roof. Periodontics is a crucial specialty because our gums are absolutely ...
Breaking Medicine Technology:
Cached News: